Work

Sustained Virologic Response 12 Weeks Post-Treatment With ABT-450/Ritonavir/Ombitasvir and Dasabuvir With Ribavirin (SAPPHIRE I and II) is Independent of Patient Subgroups

Year: 2014

Type: article

Source: The American Journal of Gastroenterology

DOI: 10.14309/00000434-201410002-00444

Authors: Maurizia Rossana Brunetto, Mihály Makara, Holger Hinrichsen, John Hanson, Michael Bennett, Eric Lawitz, Junyuan Xiong, Eoin Coakley, Tolga Baykal, Guy Neff

Institutions: Azienda Ospedaliera Universitaria Pisana, Unified Szent István and Szent László Hospital, The University of Texas at San Antonio Health Science Center, Texas Liver Institute, AbbVie (United States)

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2979221404

FWCI:

Cites:

Cited by:

Related to: 10